Randomized Trial of Metformin, Ivermectin, and Fluvoxamine for Covid-19 – New England Journal of Medicine Editorial: Time to Stop Using Ineffective Covid-19 Drugs – New England Journal of Medicine   Commentary on Twitter In this trial involving overweight or obese outpatients with Covid-19, investigators found that none of three repurposed drugs (metformin, ivermectin, and fluvoxamine) […]

The post RCT | Metformin, Ivermectin, and Fluvoxamine are not beneficial for obese outpatients with Covid-19. appeared first on Links Medicus.